Quest Diagnostics Inc
DGX173.700USD
+0.170+0.10%
Cierre 01/02, 16:00（ET）Cotizaciones retrasadas 15 min
19.28BCap. mercado
20.16P/E TTM
Más Datos de Quest Diagnostics Inc Compañía
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
Información de Quest Diagnostics Inc
Símbolo de cotizaciónDGX
Nombre de la empresaQuest Diagnostics Inc
Fecha de salida a bolsaDec 17, 1996
Director ejecutivoDavis (James E)
Número de empleados45000
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 17
Dirección500 Plaza Drive
CiudadSECAUCUS
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal07094
Teléfono19735202700
Sitio Webhttps://www.questdiagnostics.com/
Símbolo de cotizaciónDGX
Fecha de salida a bolsaDec 17, 1996
Director ejecutivoDavis (James E)
Ejecutivos de Quest Diagnostics Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
72.49K
-1.40%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
45.61K
+2.71%
Mr. Michael E. Prevoznik
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
39.12K
--
Mr. Gary M. Pfeiffer
Mr. Gary M. Pfeiffer
Independent Director
Independent Director
33.40K
-4.25%
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Independent Director
26.30K
+4.79%
Ms. Vicky B. Gregg
Ms. Vicky B. Gregg
Independent Director
Independent Director
17.04K
-6.84%
Ms. Denise M. Morrison
Ms. Denise M. Morrison
Independent Director
Independent Director
11.85K
+11.30%
Mr. Karthik Kuppusamy
Mr. Karthik Kuppusamy
Senior Vice President - Clinical Solutions
Senior Vice President - Clinical Solutions
10.25K
+0.15%
Ms. Tracey C. Doi
Ms. Tracey C. Doi
Independent Director
Independent Director
6.46K
+22.86%
Mr. Robert B. (Rob) Carter
Mr. Robert B. (Rob) Carter
Independent Director
Independent Director
2.70K
+0.22%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
72.49K
-1.40%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
45.61K
+2.71%
Mr. Michael E. Prevoznik
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
39.12K
--
Mr. Gary M. Pfeiffer
Mr. Gary M. Pfeiffer
Independent Director
Independent Director
33.40K
-4.25%
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Independent Director
26.30K
+4.79%
Ms. Vicky B. Gregg
Ms. Vicky B. Gregg
Independent Director
Independent Director
17.04K
-6.84%
Desglose de ingresos
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States
0.00
0.00%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.
Estadísticas de accionistas
Actualizado: lun., 17 de nov
Actualizado: lun., 17 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
12.77%
T. Rowe Price Associates, Inc.
6.15%
BlackRock Institutional Trust Company, N.A.
5.51%
State Street Investment Management (US)
4.70%
Boston Partners
3.63%
Otro
67.25%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
12.77%
T. Rowe Price Associates, Inc.
6.15%
BlackRock Institutional Trust Company, N.A.
5.51%
State Street Investment Management (US)
4.70%
Boston Partners
3.63%
Otro
67.25%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
55.48%
Investment Advisor/Hedge Fund
32.65%
Research Firm
4.36%
Pension Fund
2.24%
Bank and Trust
1.67%
Hedge Fund
1.52%
Sovereign Wealth Fund
1.23%
Individual Investor
0.44%
Insurance Company
0.11%
Otro
0.30%
Participación institucional
Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
1802
110.45M
99.29%
-4.04M
2025Q3
1807
110.10M
100.22%
-700.93K
2025Q2
1819
110.85M
98.75%
+3.78M
2025Q1
1805
107.66M
97.04%
-1.03M
2024Q4
1782
103.84M
96.80%
+1.47M
2024Q3
1731
102.61M
95.91%
+134.75K
2024Q2
1739
102.41M
97.25%
-2.03M
2024Q1
1743
104.12M
95.50%
-1.89M
2023Q4
1768
101.63M
97.47%
-890.08K
2023Q3
1758
103.19M
98.04%
-229.61K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
14.20M
12.77%
+16.93K
+0.12%
Sep 30, 2025
T. Rowe Price Associates, Inc.
6.84M
6.15%
-192.73K
-2.74%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
6.13M
5.51%
-81.33K
-1.31%
Sep 30, 2025
State Street Investment Management (US)
5.22M
4.7%
+38.93K
+0.75%
Sep 30, 2025
Boston Partners
4.04M
3.63%
+997.03K
+32.80%
Sep 30, 2025
JP Morgan Asset Management
3.77M
3.39%
+8.99K
+0.24%
Sep 30, 2025
Geode Capital Management, L.L.C.
3.04M
2.73%
+54.07K
+1.81%
Sep 30, 2025
Victory Capital Management Inc.
2.34M
2.11%
-465.25K
-16.56%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.91M
1.71%
+6.16K
+0.32%
Sep 30, 2025
Wells Fargo Advisors
1.76M
1.59%
-30.59K
-1.70%
Sep 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
iShares U.S. Healthcare Providers ETF
3.1%
Madison Dividend Value ETF
2.17%
State Street SPDR S&P Health Care Services ETF
1.99%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
1.81%
First Trust Total US Market AlphaDEX ETF
1.8%
Invesco S&P 500 Equal Weight Health Care ETF
1.59%
Acruence Active Hedge US Equity ETF
1.26%
First Trust Health Care Alphadex Fund
1.21%
Timothy Plan High Dividend Stock ETF
1.19%
VictoryShares US Value Momentum ETF
1.01%
Ver más
iShares U.S. Healthcare Providers ETF
Proporción3.1%
Madison Dividend Value ETF
Proporción2.17%
State Street SPDR S&P Health Care Services ETF
Proporción1.99%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
Proporción1.81%
First Trust Total US Market AlphaDEX ETF
Proporción1.8%
Invesco S&P 500 Equal Weight Health Care ETF
Proporción1.59%
Acruence Active Hedge US Equity ETF
Proporción1.26%
First Trust Health Care Alphadex Fund
Proporción1.21%
Timothy Plan High Dividend Stock ETF
Proporción1.19%
VictoryShares US Value Momentum ETF
Proporción1.01%
Dividendos
Un total de
1.26B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Nov 11, 2025
DGX.NB Interim Cash Dividend of gross USD 0.8 paid on Jan 28, 2026 going ex on Jan 13, 2026
Jan 13, 2026
Jan 28, 2026
Jan 13, 2026
Aug 13, 2025
DGX.NB Final Cash Dividend of gross USD 0.8 paid on Oct 20, 2025 going ex on Oct 03, 2025
Oct 03, 2025
Oct 20, 2025
Oct 03, 2025
May 14, 2025
DGX.NB Interim Cash Dividend of gross USD 0.8 paid on Jul 21, 2025 going ex on Jul 07, 2025
Jul 07, 2025
Jul 21, 2025
Jul 07, 2025
Jan 30, 2025
DGX.NB Interim Cash Dividend of gross USD 0.8 paid on Apr 21, 2025 going ex on Apr 07, 2025
Apr 07, 2025
Apr 21, 2025
Apr 07, 2025
Nov 12, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Jan 29, 2025 going ex on Jan 14, 2025
Jan 14, 2025
Jan 29, 2025
Jan 14, 2025
Aug 14, 2024
DGX.NB Final Cash Dividend of gross USD 0.75 paid on Oct 21, 2024 going ex on Oct 04, 2024
Oct 04, 2024
Oct 21, 2024
Oct 04, 2024
May 15, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Jul 22, 2024 going ex on Jul 08, 2024
Jul 08, 2024
Jul 22, 2024
Jul 08, 2024
Feb 01, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Apr 22, 2024 going ex on Apr 05, 2024
Apr 08, 2024
Apr 22, 2024
Apr 05, 2024
Nov 14, 2023
DGX.NB Interim Cash Dividend of gross USD 0.71 paid on Jan 31, 2024 going ex on Jan 16, 2024
Jan 17, 2024
Jan 31, 2024
Jan 16, 2024
Aug 14, 2023
DGX.NB Final Cash Dividend of gross USD 0.71 paid on Oct 23, 2023 going ex on Oct 05, 2023 with reinvestment option
Oct 06, 2023
Oct 23, 2023
Oct 05, 2023
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Quest Diagnostics Inc?
Los cinco principales accionistas de Quest Diagnostics Inc son:
The Vanguard Group, Inc. posee 14.20M acciones, lo que representa el 12.77% del total de acciones.
T. Rowe Price Associates, Inc. posee 6.84M acciones, lo que representa el 6.15% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 6.13M acciones, lo que representa el 5.51% del total de acciones.
State Street Investment Management (US) posee 5.22M acciones, lo que representa el 4.70% del total de acciones.
Boston Partners posee 4.04M acciones, lo que representa el 3.63% del total de acciones.
The Vanguard Group, Inc. posee 14.20M acciones, lo que representa el 12.77% del total de acciones.
T. Rowe Price Associates, Inc. posee 6.84M acciones, lo que representa el 6.15% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 6.13M acciones, lo que representa el 5.51% del total de acciones.
State Street Investment Management (US) posee 5.22M acciones, lo que representa el 4.70% del total de acciones.
Boston Partners posee 4.04M acciones, lo que representa el 3.63% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Quest Diagnostics Inc?
Los tres principales tipos de accionista de Quest Diagnostics Inc son:
The Vanguard Group, Inc.
T. Rowe Price Associates, Inc.
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
T. Rowe Price Associates, Inc.
BlackRock Institutional Trust Company, N.A.
¿Cuántas instituciones poseen acciones de Quest Diagnostics Inc (DGX)?
A fecha de 2025Q4, 1802 instituciones poseen acciones de Quest Diagnostics Inc, con un valor de mercado combinado de aproximadamente 110.45M, lo que representa el 99.29% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en -0.93%.
¿Cuál es la mayor fuente de ganancias de Quest Diagnostics Inc?
El FY2025Q3, el segmento empresarial -- generó la ganancia más alta para Quest Diagnostics Inc, ascendiendo a -- y representando el --% de la ganancia total.
